EDA and stroke disorder: Our previous study on neurovascular protection by S-nitrosylating agents in TBI and stroke shows that GSNO down regulated the expression of inflammatory mediators ICAM-1, ED-1, iNOS, MMP-9, protected the BBB, and improved neurological functions [2,3].